Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19-Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)
Karolyi, M, Pawelka, E, Omid, S, Koenig, F, Kauer, V, Rumpf, B, Hoepler, W, Kuran, A, Laferl, H, Seitz, T, Traugott, M, Rathkolb, V, Mueller, M, Abrahamowicz, A, Schoergenhofer, C, Hecking, M, Assinger, A, Wenisch, C, Zeitlinger, M, Jilma, B, Zoufaly, A
Published in Frontiers in pharmacology (22.07.2022)
Published in Frontiers in pharmacology (22.07.2022)
Get full text
Journal Article
COMORBIDITY & CLL DIFFERENT SCORES – DIFFERENT RESULTS
Rathkolb, V., Nösslinger, T., Gittenberger, M., Panny, M., Forjan, E., Menschel, E., Simanek, R., Fleiss, K., Schönmetzler, A., Alexandra, B., Theresia, K., Koller, E., Keil, F.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
TREATMENT OF HIGH RISK AGGRESSIVE B CELL LYMPHOMAS WITH DA EPOCH R– THE AUSTRIAN EXPERIENCE
Panny, M., Prochazka, K., Neumeister, P., Nösslinger, T., Rathkolb, V., Holzer, K., Greinix, H., Böhm, A., Keil, F.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
Treatment of high risk aggressive B cell lymphomas with DA EPOCH R—A retrospective analysis
Panny, M., Prochazka, K., Nösslinger, T., Rathkolb, V., Neumeister, P., Greinix, H., Keil, F.
Published in Hematological oncology (01.06.2017)
Published in Hematological oncology (01.06.2017)
Get full text
Journal Article